Insufficient scRNA-seq data for expression of IL20 at single-cell level.
Insufficient scRNA-seq data for expression of IL20 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 43% | 15.72 | 198 / 459 | 59% | 13.11 | 657 / 1118 |
uterus | 42% | 9.90 | 72 / 170 | 24% | 1.43 | 111 / 459 |
skin | 61% | 43.26 | 1102 / 1809 | 3% | 0.11 | 12 / 472 |
esophagus | 17% | 4.73 | 250 / 1445 | 26% | 2.10 | 48 / 183 |
adipose | 39% | 47.13 | 467 / 1204 | 0% | 0 | 0 / 0 |
ovary | 31% | 6.16 | 56 / 180 | 4% | 0.15 | 16 / 430 |
prostate | 28% | 5.92 | 69 / 245 | 4% | 0.07 | 18 / 502 |
adrenal gland | 19% | 5.29 | 50 / 258 | 9% | 0.42 | 21 / 230 |
lung | 21% | 3.18 | 123 / 578 | 6% | 0.29 | 72 / 1155 |
spleen | 27% | 4.25 | 65 / 241 | 0% | 0 | 0 / 0 |
kidney | 24% | 2.24 | 21 / 89 | 2% | 0.04 | 14 / 901 |
tonsil | 0% | 0 | 0 / 0 | 22% | 2.71 | 10 / 45 |
bladder | 10% | 0.76 | 2 / 21 | 11% | 0.55 | 54 / 504 |
liver | 15% | 4.00 | 34 / 226 | 1% | 0.07 | 6 / 406 |
thymus | 15% | 1.61 | 100 / 653 | 0% | 0.00 | 1 / 605 |
intestine | 10% | 1.12 | 99 / 966 | 1% | 0.02 | 6 / 527 |
stomach | 7% | 0.93 | 25 / 359 | 3% | 0.05 | 8 / 286 |
muscle | 9% | 1.46 | 69 / 803 | 0% | 0 | 0 / 0 |
heart | 8% | 1.77 | 66 / 861 | 0% | 0 | 0 / 0 |
pancreas | 4% | 0.25 | 13 / 328 | 2% | 0.10 | 4 / 178 |
blood vessel | 3% | 0.47 | 36 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 0.61 | 22 / 929 | 0% | 0 | 0 / 0 |
brain | 1% | 0.12 | 31 / 2642 | 0% | 0.00 | 2 / 705 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0045606 | Biological process | positive regulation of epidermal cell differentiation |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0045618 | Biological process | positive regulation of keratinocyte differentiation |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0045518 | Molecular function | interleukin-22 receptor binding |
GO_0045517 | Molecular function | interleukin-20 receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL20 |
Protein name | Interleukin family protein Interleukin-20 (IL-20) (Cytokine Zcyto10) |
Synonyms | ZCYTO10 IF2D hCG_1723949 UNQ852/PRO1801 |
Description | FUNCTION: Pro-inflammatory and angiogenic cytokine mainly secreted by monocytes and skin keratinocytes that plays crucial roles in immune responses, regulation of inflammatory responses, hemopoiesis, as well as epidermal cell and keratinocyte differentiation . Enhances tissue remodeling and wound-healing activities and restores the homeostasis of epithelial layers during infection and inflammatory responses to maintain tissue integrity . Affects multiple actin-mediated functions in activated neutrophils leading to inhibition of phagocytosis, granule exocytosis, and migration . Exert its effects via the type I IL-20 receptor complex consisting of IL20RA and IL20RB . Alternatively, can mediate its activity through a second receptor complex called type II IL-20 receptor complex composed of IL22RA1 and IL20RB . Acts as an arteriogenic and vascular remodeling factory by activating a range of signaling processes including phosphorylations of JAK2 and STAT5 as well as activation of the serine and threonine kinases AKT and ERK1/2 (By similarity). Alternatively, can activate STAT3 phosphorylation and transcriptional activity in a JAK2, ERK1/2 and p38 MAPK-dependent manner in keratinocytes . . FUNCTION: Immune regulatory cytokine. . |
Accessions | ENST00000367096.7 [Q9NYY1-1] Q9NYY1 ENST00000367098.6 [Q9NYY1-1] ENST00000391930.3 [Q9NYY1-2] A0A7R8C4W0 |